Method of diagnosing cancer susceptibility or metastatic potenti

Details Method of diagnosing cancer susceptibility or metastatic potenti Method of diagnosing cancer susceptibility or metastatic potenti

1995-02-28

1998-05-19

Sisson, Bradley L.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435 911, 435 912, 536 235, 536 2431, 935 1, 935 8, 935 77, 935 78, C12Q 168, C12P 1934, C07H 2104, C12N 1500

Patent

active

057534373

ABSTRACT:
The present invention relates, in general, to a method for diagnosing cancer susceptibility based on alterations in the nm23 gene. In particular, the present invention relates to a method of identifying individuals at risk for developing a primary cancer or at risk for suffering treatment failure, morbidity, or mortality associated with cancer. The invention further relates to a means of using genetic methods to predict individuals at increased risk for developing distant metastases.

REFERENCES:
Bevilacqua et al. Cancer Research (USA), 1989, 49/18, (5185-5190); abstract only.

Affiliated with

Also associated with

Rating

Method of diagnosing cancer susceptibility or metastatic potenti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing cancer susceptibility or metastatic potenti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing cancer susceptibility or metastatic potenti will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1851733